Tecon Biology Co., Ltd.

Tecon Biology Co., Ltd. is a leading manufacturer in the agricultural and sideline products processing sector, primarily focusing on veterinary biological products. Established in 2006 and listed on the Shenzhen Stock Exchange, the company specializes in the research, development, and production of a comprehensive range of vaccines for major livestock species, including swine, cattle, sheep, and poultry. Tecon operates three modern production bases equipped with advanced technology and adheres to international standards, ensuring a systematic supply of high-quality animal vaccines across China. The company's main business lines include veterinary vaccines, animal feed, healthy breeding services, food processing, agricultural products, and protein oil production. Tecon has established a significant presence in the feed industry with 20 production bases and a production capacity exceeding 2.8 million tons annually. Additionally, the company has developed superior breeding pig resources and operates a food service division with the capacity to process 3.5 million pigs per year. Tecon's agricultural products division focuses on high-quality forage, while its protein oil business leverages Xinjiang's cotton resources for feed production.

Obtained 28 new veterinary drug certificates for major animal disease vaccines for pigs, poultry and ruminants. Domestic leading: bovine viral diarrhea/mucosal disease inactivated vaccine (type 1, NM01 strain), swine mycoplasma pneumonia inactivated vaccine (CJ strain), swine atrophic rhinitis live vaccine (TK-MB6 strain + TK-MD8 strain), swine epidemic diarrhea inactivated vaccine (XJ-DB2 strain), porcine circovirus type 2, and mycoplasma hyopneumoniae dual inactivated vaccine (recombinant baculovirus rB-06 strains + CJ strains) First in China: Recombinant baculovirus inactivated vaccine of swine fever virus E2 protein (Rb-03 strain) , brucellosis Vaccine, Live (Strain A19-ΔVirB12) More than 200 patents of invention and utility model have been obtained (including subsidiary companies) Internationally leading: live Peste des petits ruminants vaccine (Clone9 strain), pette des petits ruminants, goat pox combined live vaccine (Clone9 strain + AV41 strain), recombinant avian influenza virus H5 subtype inactivated vaccine (H5N1, Re-6 strain, cell source).